Reversal of fibrosis and portal hypertension by Empagliflozin treatment of CCl4-induced liver fibrosis: Emphasis on gal-1/NRP-1/TGF-β and gal-1/NRP-1/VEGFR2 pathways

Ashraf A. Noah, Nesrine S. El-Mezayen, Samar O. El-Ganainy, Inas E. Darwish, Elham A. Afify

European Journal of Pharmacology · 2023 · 11 citations · 51 references

Concepts

References

51